Alliancebernstein L.P. Forma Therapeutics Holdings, Inc. Transaction History

Alliancebernstein L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$7.12 - $20.24 $2.37 Million - $6.74 Million	333,164 Added 780.24%	375,864 $7.5 Million
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $48,960 - $96,000	9,600 Added 29.0%	42,700 $294,000
Q1 2022 May 13, 2022	BUY	$8.34 - $14.69 $834 - $1,469	100 Added 0.3%	33,100 $308,000
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $40,800 - $74,670	3,000 Added 10.0%	33,000 $469,000
Q3 2021 Nov 10, 2021	SELL	$21.22 - $25.7 $48,806 - $59,110	-2,300 Reduced 7.12%	30,000 $696,000
Q2 2021 Jul 30, 2021	BUY	$22.86 - $30.95 $91,440 - $123,800	4,000 Added 14.13%	32,300 $804,000
Q1 2021 May 06, 2021	BUY	$24.58 - $42.82 $125,357 - $218,382	5,100 Added 21.98%	28,300 $793,000
Q3 2020 Nov 12, 2020	BUY	$32.95 - $50.25 $764,440 - $1.17 Million	23,200 New	23,200 $1.16 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.